Kronos Bio, Inc. Jobs and Salary Info

Kronos Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer therapeutics designed to transform patient outcomes. The company's lead product candidate, entospletinib, is a selective inhibitor of spleen tyrosine kinase (SYK) that is being evaluated in multiple clinical trials for the treatment of hematological malignancies and solid tumors. Kronos Bio is also advancing a pipeline of small molecule inhibitors targeting other key drivers of cancer, including cyclin-dependent kinases (CDKs) and MYC. The company was founded in 2018 and is headquartered in Alameda, California.